148214-90-8 Usage
General Description
(3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate is a chemical compound with a molecular formula C10H19NO3. It is a crystalline solid that is commonly used in organic synthesis and pharmaceutical research. (3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate belongs to the class of pyrrolidine carboxylates and is a derivative of tert-butyl amino acid. It has been studied for its potential medicinal properties, particularly as an inhibitor of certain enzymes and as a building block for the synthesis of pharmaceutical compounds. It has also been investigated for its potential use in the development of new drug delivery systems. Overall, (3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate is an important and versatile chemical compound with various potential applications in the field of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 148214-90-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,2,1 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 148214-90:
(8*1)+(7*4)+(6*8)+(5*2)+(4*1)+(3*4)+(2*9)+(1*0)=128
128 % 10 = 8
So 148214-90-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H18N2O3/c1-9(2,3)14-8(13)11-4-6(10)7(12)5-11/h6-7,12H,4-5,10H2,1-3H3/t6-,7-/m1/s1
148214-90-8Relevant articles and documents
Guanidine derivative and application thereof
-
Paragraph 0307; 0309-0312, (2020/06/09)
The invention relates to a guanidine derivative serving as a VAP-1 inhibitor and application of the guanidine derivative, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be us
NOVEL HETEROCYCLIC COMPOUNDS AS IRAK4 INHIBITORS
-
Page/Page column 33, (2019/06/23)
The present invention relates to novel compounds of the general formula (I) their tautomeric forms, their enantiomers, their diastereoisomers, their pharmaceutically accepted salts, or pro-drugs thereof, which are useful for the treatment or prevention of cancer and inflammatory diseases associated with Interleukin-1 Receptor Associated Kinase (IRAK), and more particularly compounds that modulate the function of IRAK4.
INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE
-
Page/Page column 157, (2018/06/30)
Compounds of formula (I') and methods of their use and preparation, as well as compositions comprising compounds of formula (I').
